•  
  •  
  •  
  •  

2026-07-21 17:37:07

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Nureca Limited Turns Around in Q1 FY27: Posts Profit Before Tax of INR 44.33 Million as Revenues Surge
  • Anthem Biosciences Limited Reports Q1 FY27 Net Profit of ₹1,199 Million on Revenues of ₹4,182 Million
  • ANVISA Approval for CuraTeQ Biologics' Biosimilars Manufacturing Facility
  • JSW Infrastructure Posts 18% Revenue Growth to ₹1,445 Crore in Q1 FY27; Operating EBITDA Reaches ₹674 Crore
  • TVS Holdings Reports Net Profit Jump of 73.8% to ₹1,173.58 Crore for Q1 FY27

Keywords Selected:  AdvancedEnzymeTechnologies

Stock Report

  • Advanced Enzyme Technologies Limited recommends final dividend of Rs. 1.35
  • Advanced Enzyme Technologies Ltd Q4FY26 consolidated profit up at Rs. 42.96 crores
  • Advanced Enzyme Technologies Limited recommends final dividend of Rs. 1.1
  • Advanced Enzyme Technologies Ltd Q4 FY2024 consolidated PAT drops to Rs. 28.31 crores
  • Advanced Enzyme Technologies Ltd increases stake in JC Biotech Pvt Ltd
  • Advanced Enzyme Technologies Ltd consolidated Q1FY24 PAT at Rs. 28.81 crores
  • Advanced Enzyme Technologies Limited declares final dividend of Rs. 1, interim dividend of Rs. 4
  • Advanced Enzyme Technologies Ltd Q4 FY2023 consolidated PAT up at Rs. 32.12 crores
  • Advanced Enzyme Technologies Ltd updates on acquisition
  • Advanced Enzyme Technologies Ltd Q3 FY23 consolidated PAT increases to Rs. 29.43 crores
  • Advanced Enzyme Technologies Ltd Q1FY23 consolidated profit at Rs. 17.87 crores
  • Advanced Enzyme Technologies Ltd recommends dividend of Rs. 1
  • Advanced Enzyme Technologies Ltd Q4FY22 consolidated PAT at Rs. 24.43 crores
  • Advanced Enzyme Technologies Limited appoints additional director
  • Advanced Enzyme Technologies posts Rs. 27.48 crores consolidated PAT in Q3 FY22
  • Advanced Enzyme Technologies Limited enters into mutually exclusive distribution agreement with Azelis Holding
  • Advanced Enzyme Technologies Ltd consolidated Q2FY22 PAT declines to Rs. 29.69 crore

Latest Post

  • Nureca Limited Turns Around in Q1 FY27: Posts Profit Before Tax of INR 44.33 Million as Revenues Surge
  • Anthem Biosciences Limited Reports Q1 FY27 Net Profit of ₹1,199 Million on Revenues of ₹4,182 Million
  • ANVISA Approval for CuraTeQ Biologics' Biosimilars Manufacturing Facility
  • JSW Infrastructure Posts 18% Revenue Growth to ₹1,445 Crore in Q1 FY27; Operating EBITDA Reaches ₹674 Crore
  • TVS Holdings Reports Net Profit Jump of 73.8% to ₹1,173.58 Crore for Q1 FY27


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025